EU drug regulator suspends 100 medicines due to faulty data from Indian CRO
To lift the suspension, companies relying on data from Indian CRO Synchron Research Services must provide alternative data demonstrating bioequivalence.
cro
May 2022
September 2018
Cyber risks may become bigger than regulatory risks for companies
A Deloitte report finds that around a third of the companies surveyed still don’t have a chief risk officer and risk management ranks high on the board agenda of only 35% firms
